HMS and the Warren Alpert Foundation announced yesterday that an annual prize recognizing lab discoveries to advance human health will go to four scientists who developed the drug bortezomib used in treatment of multiple myeloma, a cancer of the blood. The recipients are: Julian Adams of Infinity Pharmaceuticals, Alfred Goldberg, HMS professor of cell biology, Kenneth Anderson, the Kraft Family Professor of Medicine at Dana-Farber Cancer Institute and Paul Richardson, the R.J. Corman Associate Professor of Medicine at Dana-Farber Cancer Institute.
